CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Goodwill in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Charles River Laboratories International, Inc. quarterly Goodwill history and growth rate from Q2 2010 to Q2 2024.
  • Charles River Laboratories International, Inc. Goodwill for the quarter ending June 29, 2024 was $3.08B, a 5.59% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.08B +$163M +5.59% Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $3.07B +$169M +5.81% Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $3.1B +$245M +8.6% Dec 30, 2023 10-Q 2024-08-07
Q3 2023 $2.88B +$109M +3.91% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $2.92B +$56.3M +1.97% Jul 1, 2023 10-Q 2023-08-09
Q1 2023 $2.9B +$206M +7.63% Apr 1, 2023 10-Q 2023-05-11
Q4 2022 $2.85B +$138M +5.09% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $2.78B +$39.7M +1.45% Sep 24, 2022 10-Q 2022-11-02
Q2 2022 $2.86B +$320M +12.6% Jun 25, 2022 10-Q 2022-08-03
Q1 2022 $2.7B +$805M +42.6% Mar 26, 2022 10-Q 2022-05-04
Q4 2021 $2.71B +$903M +49.9% Dec 25, 2021 10-K 2023-02-22
Q3 2021 $2.74B +$959M +53.9% Sep 25, 2021 10-Q 2021-11-03
Q2 2021 $2.54B +$804M +46.3% Jun 26, 2021 10-Q 2021-08-04
Q1 2021 $1.89B +$159M +9.17% Mar 27, 2021 10-Q 2021-05-04
Q4 2020 $1.81B +$269M +17.4% Dec 26, 2020 10-K 2022-02-16
Q3 2020 $1.78B +$256M +16.8% Sep 26, 2020 10-Q 2020-11-09
Q2 2020 $1.74B +$209M +13.7% Jun 27, 2020 10-Q 2020-08-05
Q1 2020 $1.73B +$486M +39% Mar 28, 2020 10-Q 2020-05-07
Q4 2019 $1.54B +$293M +23.5% Dec 28, 2019 10-K 2022-02-16
Q3 2019 $1.52B +$269M +21.5% Sep 28, 2019 10-Q 2019-11-06
Q2 2019 $1.53B +$272M +21.7% Jun 29, 2019 10-Q 2019-07-31
Q1 2019 $1.25B +$410M +49% Mar 30, 2019 10-Q 2019-05-07
Q4 2018 $1.25B +$442M +54.9% Dec 29, 2018 10-K 2021-02-17
Q3 2018 $1.25B +$452M +56.5% Sep 29, 2018 10-Q 2018-11-07
Q2 2018 $1.25B +$478M +61.6% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $836M +$79.9M +10.6% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $805M +$17.4M +2.21% Dec 30, 2017 10-K 2020-02-11
Q3 2017 $800M +$36.7M +4.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $776M +$21.5M +2.85% Jul 1, 2017 10-Q 2017-08-09
Q1 2017 $756M +$322M +74.2% Apr 1, 2017 10-Q 2017-05-10
Q4 2016 $788M +$349M +79.5% Dec 31, 2016 10-K 2019-02-13
Q3 2016 $764M +$345M +82.6% Sep 24, 2016 10-Q 2016-11-02
Q2 2016 $755M +$438M +138% Jun 25, 2016 10-Q 2016-08-03
Q1 2016 $434M +$121M +38.6% Mar 26, 2016 10-Q 2016-05-04
Q4 2015 $439M +$118M +36.7% Dec 26, 2015 10-K 2018-02-13
Q3 2015 $418M +$129M +44.5% Sep 26, 2015 10-Q 2015-11-04
Q2 2015 $317M +$20.4M +6.87% Jun 27, 2015 10-Q 2015-07-30
Q1 2015 $313M +$82.8M +36% Mar 28, 2015 10-Q 2015-04-30
Q4 2014 $321M +$90.4M +39.2% Dec 27, 2014 10-K 2017-02-14
Q3 2014 $289M +$60.1M +26.2% Sep 27, 2014 10-Q 2014-10-30
Q2 2014 $297M +$69.5M +30.5% Jun 28, 2014 10-Q 2014-08-07
Q1 2014 $230M +$3.24M +1.43% Mar 29, 2014 10-Q 2014-04-30
Q4 2013 $231M +$22.1M +10.6% Dec 28, 2013 10-K 2016-02-12
Q3 2013 $229M +$21.9M +10.5% Sep 28, 2013 10-Q 2013-10-30
Q2 2013 $228M +$31.3M +16% Jun 29, 2013 10-Q 2013-07-31
Q1 2013 $227M +$28.2M +14.2% Mar 30, 2013 10-Q 2013-05-08
Q4 2012 $209M +$11M +5.59% Dec 29, 2012 10-K 2015-02-17
Q3 2012 $207M +$7.62M +3.81% Sep 29, 2012 10-Q 2012-11-01
Q2 2012 $196M -$6.2M -3.07% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $199M -$3.18M -1.57% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $198M -$877K -0.44% Dec 31, 2011 10-K 2014-02-25
Q3 2011 $200M -$305M -60.4% Sep 24, 2011 10-Q 2011-11-02
Q2 2011 $202M -$298M -59.6% Jun 25, 2011 10-Q 2011-08-03
Q1 2011 $202M Mar 26, 2011 10-Q 2011-05-04
Q4 2010 $198M Dec 25, 2010 10-K 2013-02-27
Q3 2010 $505M Sep 25, 2010 10-Q 2010-11-04
Q2 2010 $501M Jun 26, 2010 10-Q 2010-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.